Study | Reason for exclusion |
---|---|
ACTRN12610001087044 | Trial registry entry suggested two parts of a trial of which only the second was of interest to this review. Contact with trialists confirmed that the part of interest was registered and reported on separately (ACTRN: 12614000088640, STRUCTURE study). |
Adgey 1992 | Wrong patient population |
Ammon 2001 | Wrong study design |
Andersson 1996 | Wrong patient population |
Andersson 1999 | Wrong patient population |
Andersson 2000 | Wrong patient population |
Anonymous 1996 | Wrong patient population |
Anonymous 1999 | Wrong intervention |
Anonymous 2000 | Wrong patient population |
Anonymous 2001 | Wrong study design |
Anonymous 2002 | Wrong study design |
Anonymous 2003 | Wrong comparator |
Anonymous 2003a | Wrong study design |
Anonymous 2003b | Wrong study design |
Anonymous 2003c | Wrong patient population |
Anonymous 2005 | Wrong patient population |
Anonymous 2008 | Wrong study design |
Anonymous 2008a | Wrong study design |
Anonymous 2013 | Wrong study design |
ANZ HF carvedilol | Subgroup of participants of interest (LVEF = 40‐44%). We did not receive a response from the trialists to our enquiry for details on the subgroup of interest. |
Aoyama 2007 | Wrong study design |
Apostolovic 2013 | Wrong comparator |
Apostolovic 2014a | Wrong comparator |
Apostolovic 2014b | Wrong comparator |
Arena 2007 | Wrong study design |
Armstrong 1999 | Wrong study design |
Aronow 1991 | Wrong study design |
Aronow 2001 | Wrong study design |
Axelsson 2015 | Wrong patient population |
Balaban 2007 | Turkish paper. Translated methods and data extraction. Unclear if participants had heart failure. We did not receive a response from the investigator when we asked for clarification. |
Bao 2005 | Wrong population |
Barr 1995 | Wrong patient population |
Barrios 2009 | Wrong patient population |
Barry 2003 | Wrong study design |
Bartels 1999 | Wrong patient population |
Baruch 1999 | Ineligible participants. Emailed trialists to clarify inclusion criteria. Response received: "Our study was confined to individuals with a reduced ejection fraction and the data therefore would not be applicable to your quest." |
Baruch 2004 | Wrong patient population |
Bauersachs 2004 | Wrong study design |
Baumhakel 2008 | Wrong study design |
Bellenger 2004 | Wrong patient population |
Berry 2001 | Wrong study design |
Bettencourt 1999 | Wrong study design |
Beygui 2016 | Wrong patient population |
Blagodar 2003 | Wrong patient population |
Blomer 1990 | Wrong study design |
Borghi 2011 | Wrong comparator |
Borgi 1990 | Wrong patient population |
Borlaug 2014 | Wrong study design |
Bornkessel 1992 | Wrong patient population |
Bounhoure 1991 | EF not reported. Could not identify current contact details. |
Braunwald 2004 | Wrong patient population |
Brilla 1989 | Wrong study design |
Brilla 1991 | EF unclear, unclear whether allocation was random, unable to identify current contact details. |
Bristow 1994 | Wrong patient population |
Bristow 1996 | Wrong patient population |
Bussmann 1987 | EF unclear. We did not receive a response to our enquiry for details. |
Butler 2017 | Wrong patient population |
Cafaro 2010 | Wrong study design |
Cardoso 1999 | Wrong study design |
Castagno 2010 | Wrong patient population |
Choi 2001 | Wrong patient population |
Cicoira 2002 | subgroup of participants of interest; we did not receive a response from the trialist to our enquiry for details. |
Cleland 1984 | unclear EF. contacted trialists. no response |
Cleland 1999 | Wrong patient population |
Cleland 2001 | Wrong patient population |
Cleland 2003 | Wrong patient population |
Cleland 2004 | Wrong study design |
Cleland 2006 | Wrong study design |
Cleland 2007 | Wrong study design |
Cleland 2010 | Wrong study design |
Cleland 2011 | Wrong study design |
Cleland 2013 | Wrong study design |
Cohen‐Solal 2005 | Wrong patient population |
Cohn 1993 | Wrong study design |
Cohn 1996a | Wrong study design |
Cohn 1996b | Wrong study design |
Cohn 2007 | Wrong study design |
Coletta 2008 | Wrong study design |
Coletta 2009 | Wrong study design |
Comin‐Colet 2002 | Wrong study design |
CONSENSUS | EF unclear. We did not receive a response from the trialists to our enquiry for details. |
CONSENSUS II | Mean EF suggests a subgroup of eligible participants. We did not receive a response from the trialists to our enquiry. |
Conti 2005 | Wrong study design |
Corder 1993 | EF unclear. Unable to identify current contact details. |
Crouse 2011 | Wrong study design |
Dahlstrom 2007 | Wrong study design |
Davie 2001 | Wrong study design |
De Melo 2011 | Wrong comparator |
de Teresa 1995 | Wrong study design |
DeBock 1994 | EF unclear. Unable to find current contact details for trialists. |
Dekleva 2012 | Wrong comparator |
Demers 2001 | Wrong patient population |
Desai 2013 | Wrong study design |
Deswal 2010 | EF unclear. We did not receive a response from trialists to our query on the clarification of inclusion criteria. |
Ding 2008 | Wrong comparator |
Ditiatkov 1999 | Wrong study design |
Donal 2008 | Wrong study design |
Dragana 2015 | Wrong comparator |
Edner 2013 | Wrong study design |
Eichhorn 1994 | subgroup of participants of interest; did not receive a response from trialists to our enquiry. |
Eichhorn 2003 | Wrong patient population |
Er 2005 | Wrong study design |
Ertl 1999 | Wrong study design |
EudraCT 2004‐004169‐13 | Trial registry record states completed but no contact details given an no published results identifiable. Sponsor: South Manchester University Hospital NHS Trust. Emailed sponsor to ask whether results are available. Unclear whether http://www.isrctn.com/ISRCTN77645264 is the same trial. Tried to contact investigator but email was undeliverable. |
Fauchier 2009 | Wrong study design |
Feola 2003 | Wrong study design |
Flammer 2013 | Wrong patient population |
Flather 2016 | Wrong study design |
Flesch 2006 | Wrong study design |
Follath 1996 | Wrong study design |
Fonarow 2004 | Wrong study design |
Fonarow 2007 | Wrong patient population |
Fowler 1999 | Wrong study design |
Franciosa 2002 | Wrong intervention |
Fukunami 1991 | Wrong study design |
Galinier 2007 | Wrong study design |
Galloe 2006 | Potential eligible subgroup. Did not receive a response from trialists to our enquiry for outcome data for subgroup. |
Gardner 2003 | Wrong study design |
Gardner 2004 | Wrong study design |
Ghali 2002 | Wrong patient population |
Gheorghiade 2009 | Wrong patient population |
Good 1994 | Wrong patient population |
Goodfield 1999 | Wrong patient population |
Gottlieb 1996 | Wrong patient population |
Grajek 2008 | Review |
Greenberg 1996 | Wrong patient population |
Gremmler 2000 | EF unclear. Unable to identify current contact details. |
Groenning 2000 | Wrong patient population |
Groenning 2001 | Wrong study design |
Groenning 2002 | Wrong patient population |
Gruner 2007 | Wrong patient population |
Guazzi 1998 | Wrong patient population |
Guazzi 1999 | Wrong patient population |
Gøtzsche 1992 | subgroup with HF and LVEF >40%. We did not receive a response from trialists to our enquiry. |
Hanping 1997 | Wrong study design |
Hara 2000 | Wrong comparator |
Hauf 1993 | Wrong study design |
Hole 2004 | Wrong patient population |
Holland 2010 | Limited information in conference abstract. Response to our enquiry for further details received: "the data you've requested was not collected on this group of patients beyond what has been published in that abstract". As we could not confirm whether the participants meet our inclusion criteria, this study was excluded. |
Hong 2003 | Wrong intervention |
Hoppe 2007 | Wrong study design |
Hori 2004 | Wrong patient population |
Hung 2010 | Wrong study design |
IRIS‐HF | Response from trialists received when asked for outcome data for subgroup of interest: no data specifically for participants in subgroup of interest (LVEF 40‐45%) provided. Confirmed that QoL, mortality and HF hospitalisation were not formal endpoints. Hyperkalaemia was not shown by any participants. |
Ito 2012 | Wrong study design |
Jamieson 1991 | Wrong study design |
Jellis 2014 | HF/EF unclear. No response to our enquiry for details. |
Jessup 2003 | Wrong study design |
Jong 2010 | Wrong study design |
Kanoupakis 2008 | Wrong patient population |
Kapel'ko 2011 | Wrong study design |
Kasama 2007 | Wrong comparator |
Keren 1992 | Wrong patient population |
Keren 1994 | Wrong patient population |
Khalid 2013 | Wrong study design |
Khand 2015 | Wrong patient population |
Kikuchi 2016 | Wrong patient population |
Kimura 2011 | Wrong patient population |
Kinugawa 2007 | Wrong study design |
Kjekshus 2007 | Wrong study design |
Kjøller‐Hansen 1998 | Wrong patient population |
Kleber 1991a | No participants with heart failure with preserved ejection fraction (confirmed by trialist via email on 20 November 2017). |
Kleber 1991b | Heart failure was not an inclusion criteria (confirmed by trialist via email on 15 November 2017). |
Kongstad‐Rasmussen 1998 | EF unclear ("ejection fraction measurement was not part of the protocol") |
Krum 1996 | Wrong patient population |
Krum 2015 | Wrong patient population |
Kulbertus 2003 | wrong study design |
Kuznar 2003 | Wrong patient population |
Lang 1995 | cross‐over trial |
Larsen 1996 | EF unclear. Contacted trialists. Response: data are no longer available. |
Lechat 1993 | LVEF unclear, otherwise eligible. Emailed investigator but did not receive a response. |
Leonetti 1999 | Wrong patient population |
Lewis 1988 | EF unclear. Unable to find current contact. |
Li 2005 | Wrong population |
Liebson 2004 | Wrong patient population |
Lindenfeld 2001 | Wrong patient population |
Lindsay 1999 | Wrong study design |
Liu 2014 | Wrong patient population |
Logeart 2006 | Wrong study design |
Lopez 2000 | Wrong study design |
Lou 2009 | Wrong study design |
Luo 2007 | Wrong study design |
Ma 2005 | Wrong population |
MacGregor 2009 | Wrong patient population |
Mak 2008 | EF unclear. unable to find current contact details for trialist. |
Malnick 2007 | Wrong patient population |
Maron 2013 | LVEF unclear. Contacted trialists. No response. |
Mazayev 1998 | LVEF unclear, otherwise eligible. Unable to find current contact details for investigators. |
McAnulty 2004 | Wrong comparator |
McCullough 2012 | Wrong patient population |
McIlwain 1997 | Wrong study design |
McKelvie 2012 | Wrong study design |
McMurray 2000 | Wrong study design |
McMurray 2004 | Wrong study design |
Melo 2011 | Wrong comparator |
Melo 2012 | Wrong comparator |
Messias 2016 | Wrong study design |
Meuleman 2007 | wrong participants |
Mitrovic 2005 | Wrong study design |
Mochizuki 2004 | retraction |
Morales 2011 | Wrong patient population |
Murdoch 2001 | Wrong patient population |
NCT00293150 | terminated due to lack of eligible participants |
NCT00523757 | Trial did not take place as planned (as per information from trialists: "We abandoned this study as we could not adequately recruit. No results to present.") |
NCT01691118 | Completed but no publication with results identified. Emailed trialists to ask for clarification on comparator (placebo or conventional antihypertensive treatment). No response. |
Nodari 2003 | Wrong comparator |
Nunez 2016 | Wrong study design |
O'Callaghan 1995 | Wrong study design |
O'Keefe 2008 | Wrong patient population |
O'Keeffe 2015 | Wrong comparator |
O'Meara 2012 | Wrong patient population |
Ostergren 2004 | Wrong study design |
Palazzuoli 2005 | Wrong patient population |
Paolisso 1992 | Wrong study design |
Paraskevaidis 2006 | Wrong patient population |
Park 2016 | Wrong comparator |
Patten 1997 | Wrong patient population |
Pennell 2000 | Wrong patient population |
Pierard 2002 | Wrong patient population |
Pina 2004 | Wrong study design |
Pitt 2005 | Wrong patient population |
Pitt 2008 | Wrong patient population |
Pitt 2011 | Wrong intervention |
Pourdjabbar 2015 | Wrong study design |
Premkumar 2016 | Wrong patient population |
Quaife 1998 | Wrong patient population |
Ramaswamy 2003 | Wrong study design |
Remme 2001 | Wrong patient population |
Remme 2004 | Wrong patient population |
Remme 2005 | Wrong patient population |
Rimatori 1990 | LVEF unclear, otherwise eligible. Unable to find current contact details for investigators. |
Roongsritong 2005 | Wrong patient population |
Rosa 2011 | Wrong intervention |
Rosenkranz 2003 | Wrong study design |
Rossignol 2011 | Wrong patient population |
Sakai 2011 | Wrong intervention |
Sanderson 1998 | Subgroup of interest LVEF 40‐45%. Investigator responded to our enquiry for data: "the mean EF was only 26.9% and I doubt any of the patients were in the group of EF 40% to <45%. [...] I do not have the original data now." |
Sanghera 2011 | Wrong study design |
Santulli 2015 | Wrong study design |
Sardu 1991 | LVEF not specified as an inclusion criteria, mean LVEF at baseline 35.4, 4.7%. Could not find current contact details for investigator. |
Schindler 2008 | Wrong patient population |
Schwab 2009 | Wrong study design |
Segovia 2008 | Wrong study design |
Shimamoto 2007 | Wrong patient population |
Sidorenko 2008 | Wrong patient population |
Silva 2014 | Wrong patient population |
Smith 2012 | Wrong study design |
Spoto 2002 | Wrong study design |
Stecker 2005 | Wrong patient population |
Stiefelhagen 2006 | Wrong study design |
Struthers 2004 | Wrong study design |
Swedberg 1996 | Wrong study design |
Swedberg 1999 | Wrong study design |
Szajnbok 1993 | Portuguese paper. Reported outcomes not of interest but subgroup of participants eligible. Emailed investigators to ask about measured outcomes for subgroup of interest. Response: data not available. |
Szymanski 2009 | Wrong study design |
Taheri 2009 | subgroup of interest LVEF 40‐45%. Contacted investigators. No response. |
Takekoshi 2004 | Wrong study design |
Tala 2011a | Wrong patient population |
Tala 2011b | Wrong patient population |
Tan 2013 | Wrong study design |
Tatsumi 2006 | Wrong study design |
Taylor 2003 | Wrong intervention |
Teerlink 2003 | Wrong patient population |
Tereshchenko 2005 | Wrong comparator |
Thornton 2004 | Wrong study design |
Thune 2008 | Wrong patient population |
Tinoco 2004 | Wrong study design |
Tsutamoto 2000 | Wrong study design |
Tsutamoto 2001 | Subgroup of interest (LVEF 40‐45%). Emailed investigators. No response. |
Tsutamoto 2005 | Wrong study design |
Tumasyan 2010 | Wrong comparator |
Umemoto 2003 | Wrong study design |
Uusimaa 2001 | Wrong comparator |
Van den Berg 1993 | Wrong study design |
Van den Berg 1995 | LVEF unclear; response to our enquiry for details: cannot provide data |
Vasiuk 2001 | Wrong study design |
Vincent 2012 | Wrong patient population |
Vizir 2000 | Wrong patient population |
Vizzardi 2010 | Wrong patient population |
Vizzardi 2012 | LVEF unclear. Emailed investigators. No response. |
Vizzardi 2015a | Wrong study design |
Vizzardi 2015b | Wrong patient population |
Volpe 1992 | Subgroup of interest LVEF 40‐45%. We received a response to our enquiry for more details on the subgroup of interest confirming that the study was conducted in "patients with reduced EF". |
Volpe 2010 | Wrong patient population |
Voors 2008 | Wrong study design |
Waagstein 2003 | Wrong patient population |
Waldo 1995 | Wrong patient population |
Waldo 1996 | Wrong patient population |
Warner 1999 | Wrong patient population |
Weinberg 2001 | Wrong study design |
Weintraub 2005 | Wrong patient population |
Weir 2011 | Wrong patient population |
Wong 2002 | Wrong patient population |
Wong 2004 | Wrong patient population |
Woodley 1991 | Wrong patient population |
Wright 2014 | Wrong patient population |
Wu 2002 | LVEF unclear, otherwise eligible. Unable to find current contact details for investigators. |
Xu 2007 | Wrong population |
Yamamoto 2005 | Wrong study design |
Yan 2012 | LVEF unclear, otherwise eligible. Unable to find current contact details for investigators. |
Yoshihiro 2011 | Wrong intervention |
Young 2004 | Wrong patient population |
Zeng 2006 | Wrong patient population |